Opsens Inc. (TSXV: OPS) and DexCom Inc. (NASDAQ: DXCM) are among a number of companies that received an analyst upgrade or downgrade recently, including one with upside potential of more than 108%.
Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
---|---|---|---|---|---|---|---|---|---|
Pengrowth Energy Corp | TSX | PGF | 4.24 | 2,247.8 | Upgrade to buy from sell | Sam La Bell | Veritas Investment Research Co | 5.45 | 28.5% |
GuestLogix Inc | TSX | GXI | 0.93 | 85.5 | Upgrade to buy from hold | Mona Nazir | Laurentian Bank Securities | 1.30 | 39.8% |
Teranga Gold Corp | TSX | TGZ | 0.42 | 148.2 | Upgrade to buy from hold | Filipe Martins | GMP | 0.60 | 42.9% |
Opsens Inc | TSXV | OPS | 0.60 | 35.9 | Initiate with outperform | Douglas Miehm | RBC Capital Markets | 1.25 | 108.3% |
Journey Energy Inc | TSX | JOY | 7.44 | 320.5 | Downgrade to market perform from outperform | Katrina L Karkkainen | FirstEnergy Capital Corp | 8.00 | 7.5% |
Veritas Investment Research Co upgraded Pengrowth Energy Corp (TSX: PGF), engaged in the development, production, acquisition and exploration of oil and natural gas, to buy from sell with a price target of C$5.45, indicating an upside of 28.5% from current levels.
GuestLogix Inc (TSX: GXI), engaged in providing comprehensive merchandising, payment and business intelligence technology to the passenger travel industry, was upgraded by Laurentian Bank Securities to buy from hold with a price target of C$1.30, indicating an upside potential of 39.8% from current levels.
GMP upgraded Teranga Gold Corp (TSX: TGZ), engaged in the production and sale of gold, as well as related activities such as exploration and mine development, to buy from hold with a price target of C$0.60, indicating an upside of 42.9% from current levels.
RBC Capital Markets initiated coverage on Opsens Inc (TSXV: OPS), engaged in developing, manufacturing and supplying a range of fiber optic sensors and associated signal conditioners, with an outperform rating assigning a 12-month price target of C$1.25, indicating an upside of 108.3% from current levels.
FirstEnergy Capital Corp downgraded Journey Energy Inc (TSX: JOY), engaged in the exploration, development and production of oil and natural gas in the Western Canada Sedimentary Basin, to market perform from outperform with a price target of C$8.00, indicating an upside of 7.5% from current levels.
Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
---|---|---|---|---|---|---|---|---|---|
Genesis Energy LP | NYSE | GEL | 48.94 | 4,563.7 | Upgrade to outperform from neutral | Ethan H Bellamy | Robert W. Baird & Co | 57.00 | 16.5% |
SLM Corp | NASDAQ | SLM | 9.72 | 4,113.2 | Upgrade to buy from neutral | Eric Beardsley | Goldman Sachs | 11.50 | 18.3% |
Anixter International Inc | NYSE | AXE | 85.29 | 2,800.7 | Upgrade to buy from hold | Brent Rakers | Thompson Research Group | 106.00 | 24.3% |
DexCom Inc | NASDAQ | DXCM | 44.48 | 3,357.2 | Initiate with buy | Erik Shoger | Northcoast Research | 55.00 | 23.7% |
LinnCo LLC | NASDAQ | LNCO | 21.61 | 2,777.8 | Downgrade to neutral from outperform | Abhiram Rajendran | Credit Suisse | 27.00 | 24.9% |
Robert W. Baird & Co upgraded Genesis Energy LP (NYSE: GEL), engaged in owning and operating crude oil gathering, marketing, and pipeline operations, to outperform from neutral with a price target of $57.00, indicating an upside of 16.5% from current levels.
SLM Corp (NASDAQ: SLM), engaged in providing education funding, originating and servicing of U.S. government guaranteed and private student loans, was upgraded by Goldman Sachs to buy from neutral raising its price target to $11.50 from $9.50, indicating an upside potential of 18.3% from current levels.
Thompson Research Group upgraded Anixter International Inc (NYSE: AXE), engaged in providing security systems and solutions, enterprise cabling, and distributing electrical and electronic wire, to buy from hold with a price target of $106.00, indicating an upside of 24.3% from current levels.
Northcoast Research initiated coverage on DexCom Inc (NASDAQ: DXCM), engaged in the business of designing and developing continuous glucose monitoring systems for people with diabetes, with a buy rating assigning a 12-month price target of $55.00, indicating an upside of 23.7% from current levels.
LinnCo LLC (NASDAQ: LNCO), engaged in the acquisition and development of oil & natural gas properties in the U.S., was downgraded by Credit Suisse to neutral from outperform by reducing its price target to $27.00 from $30.00, implying an upside potential of 24.9% from current levels.